Anti-PAD1 Monoclonal Antibody (Clone 6B4) | A2311

Protein arginine deiminases (PADs) are guanidine-modifying enzymes that catalyze the post-translational modification of target proteins by converting arginine to citrulline. Excessive citrullination of proteins may result in disease states. PAD1 is expressed in uterus and throughout the epidermis, and is involved in the late stages of epidermal differentiation and possibly hair follicle formation. Disruption in PAD1 activity is associated with certain skin diseases and Laing Distal Myopathy.

A2311 | Anti-PAD1 Monoclonal Antibody (Clone 6B4) DataSheet

Antibody Target: Human PAD1

Target Alternative Name: Peptidyl Arginine Deiminase 1; PDI1; Protein-Arginine Deiminase Type I; Peptidylarginine Deiminase I; HPAD-Colony 10; EC 3.5.3.15; HPAD10; PDI; PADI1

Tag Line: Catalyzes the conversion of arginine into citrulline in distinct proteins

Category: GM-CSF

Host: Mouse

Isotype: Mouse IgG2b

Species Reactivities: Human

Immunogen Sequence: Recombinant human PAD1 protein

Accession #: Q9ULC6

Gene ID: 29943

Appearance: Liquid

Form: Mouse monoclonal

Concentration:

Formulation: In PBS, pH 7.2, 50% glycerol, 0.1% BSA, 0.02% sodium azide

Purification: Protein G purification

Application: Western Blotting ELISA

Positive Control:

Application And Usages:

Country of Animal Origin: USA

Country of Manufacture: USA

Usage: For Research Use Only! Not to be used in humans.

Handling: The antibody solution should be gently mixed before use.

Western Blot Verified: TRUE

Immunocytochemistry Verified: TRUE

Immunofluorescence Verified: FALSE

Immunoprecipitation Verified: FALSE

FACS Verified: FALSE

ELISA Verified: FALSE

ChIP Verified: FALSE

Dot Blot Verified: FALSE

Flow Cytometry Verified: FALSE